| Members |
targetComponentId |
| Adiposa cornea dystrophy |
Fatty degeneration of cornea |
| Adiposity (disorder) |
Obesity (disorder) |
| Adiposity |
obésité alimentaire |
| Adiposity (disorder) |
obésité alimentaire |
| Adiposity (disorder) |
Obesity (disorder) |
| Adiposity (disorder) |
obésité alimentaire |
| Adiposity |
Obesity (disorder) |
| ajustement d'une prothèse ou d'un appareil maxillofacial |
Adjust mandibular resection prosthesis |
| ajustement d'une prothèse ou d'un appareil maxillofacial |
Adjust extraoral maxillofacial prosthesis |
| Adjustment (procedure) |
Adjustment (attribute) |
| Adjustment (procedure) |
Adjustment (procedure) |
| Adjustment reaction NOS |
Adjustment disorder |
| Adjustment to: [skeletal traction] or [Kirschner wire] (procedure) |
Adjustment to Kirschner wire |
| Adjustment to: [skeletal traction] or [Kirschner wire] (procedure) |
Adjustment to skeletal traction of bone |
| Adjuvant |
Immunologic adjuvant (substance) |
| Adjuvant |
Freund's adjuvant (substance) |
| Adjuvant |
Incomplete adjuvant |
| Administration of botulism antitoxin |
Injection of botulism antitoxin (procedure) |
| Administration of botulism antitoxin |
Infusion of botulism antitoxin (procedure) |
| Administration of botulism antitoxin |
Administration of botulism antitoxin (procedure) |
| Administration of cancer treatment |
administration d'un agent antinéoplasique |
| Administration of cancer treatment (procedure) |
administration d'un agent antinéoplasique |
| Administration of cancer treatment |
administration d'un agent antinéoplasique |
| Administration of eye drugs -[no drugs here] (disorder) |
Applying medication to eyes |
| Administration of eye drugs -[no drugs here] (disorder) |
Instilling eye drops |
| Administration of human papilloma virus type 4 vaccine (procedure) |
Administration of vaccine product containing only Human papillomavirus 6, 11, 16 and 18 antigens (procedure) |
| Administration of oral typhoid live vaccine (procedure) |
Administration of live attenuated Salmonella enterica subspecies enterica serovar Typhi antigen only vaccine product via oral route |
| Administration of pneumococcal 7-valent conjugate vaccine (procedure) |
Administration of pneumococcal 7-valent conjugate vaccine |
| Administration of pneumococcal polysaccharide 23 valent vaccine |
Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F capsular polysaccharide antigens (procedure) |
| Administration of saline solution |
Infusion of saline solution |
| Administration of saline solution |
Intra-arterial infusion of saline |
| Administration of steroid |
Injection of steroid |
| Administration of steroid |
Infusion of steroid |
| Administration of steroid |
administration de stéroïde |
| Administration of subcutaneous zoster virus live vaccine |
Administration of live attenuated Human alphaherpesvirus 3 vaccine via subcutaneous route |
| Administration of tetanus antitoxin |
Anti-tetanus immunoglobulin injection (procedure) |
| Administration of tetanus antitoxin |
Administration of tetanus antitoxin (procedure) |
| Administration of tetanus antitoxin |
Injection of tetanus antitoxin (procedure) |
| Administration of tetanus antitoxin |
Infusion of tetanus antitoxin (procedure) |
| Administration of tetanus, diphtheria, and acellular pertussis vaccine |
Administration of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens (procedure) |
| Administration of therapeutic medication (procedure) |
Administration of substance (procedure) |
| Administration of therapeutic medication (procedure) |
administration de médicaments |
| Administration of therapeutic substance |
Administration of substance (procedure) |
| administration d'une substance thérapeutique |
administration de médicaments |
| Administration of therapeutic substance |
administration de médicaments |
| administration d'une substance thérapeutique |
Administration of substance (procedure) |
| Administration of therapeutic substance into artery |
Administration of substance via intraarterial route (procedure) |
| Administration of therapeutic substance into artery |
Administration of drug or medicament via intraarterial route (procedure) |
| Administration of varicella live vaccine (procedure) |
Administration of live attenuated Human alphaherpesvirus 3 vaccine |
| Administration: [prevention &/or screening] or [clinic monitoring] or [contraceptive] |
Screening procedure |
| Administration: [prevention &/or screening] or [clinic monitoring] or [contraceptive] (procedure) |
Screening procedure |
| Administration: [prevention &/or screening] or [clinic monitoring] or [contraceptive] |
Preventive procedure |
| Administration: [prevention &/or screening] or [clinic monitoring] or [contraceptive] (procedure) |
Preventive procedure |
| Admission certification (procedure) |
attestation d'admission |
| Admission certification (procedure) |
Admission review |
| Adolescent lymphedema |
Hereditary lymphedema type II (disorder) |
| Adolescent lymphoedema (disorder) |
Hereditary lymphedema type II (disorder) |
| Adolescent mastitis (& [acute]) (disorder) |
Adolescent mastitis |
| Adolescent mastitis (& [acute]) (disorder) |
Acute adolescent mastitis |
| Adopted,re-reg.-new name: [FP22] or [GP22] (finding) |
Patient deregistration status |
| Adopted,re-reg.-new name: [FP22] or [GP22] |
Patient deregistration status |
| Adoptive immunity |
Adoptive immunity, function (observable entity) |
| Adoptive immunity |
Acquired immunity, function (observable entity) |
| Adrenal autoantibodies (& level) |
Antibody to adrenal antigen measurement |
| Adrenal cortex antibody level (procedure) |
Adrenal cortex antibody measurement |
| Adrenal cortical hypofunction |
Primary adrenocortical insufficiency (disorder) |
| Adrenal cortical hypofunction |
Adrenal cortical hypofunction (disorder) |
| Adrenal corticosteroid poisoning NOS |
Poisoning caused by corticosteroid and/or corticosteroid derivative |
| Adrenal disorders: [other] or [Conn's syndrome] or [hyperaldosteronism] or [Waterhouse-Friderichen] |
Hyperaldosteronism |
| Adrenal disorders: [other] or [Conn's syndrome] or [hyperaldosteronism] or [Waterhouse-Friderichen] (disorder) |
Primary aldosteronism |
| Adrenal disorders: [other] or [Conn's syndrome] or [hyperaldosteronism] or [Waterhouse-Friderichen] |
Primary aldosteronism |
| Adrenal disorders: [other] or [Conn's syndrome] or [hyperaldosteronism] or [Waterhouse-Friderichen] (disorder) |
Hyperaldosteronism |
| Adrenal haemorrhage (& [adrenocortical]) (disorder) |
Adrenocortical haemorrhage |
| Adrenal haemorrhage (& [adrenocortical]) (disorder) |
Adrenal haemorrhage |
| Adrenal hypertrophy or hyperplasia |
Enlarged adrenal gland |
| Adrenal hypertrophy or hyperplasia |
Adrenal hyperplasia (disorder) |
| Adrenal imaging |
Adrenal radioisotope scan (procedure) |
| Adrenal imaging |
Adrenal imaging (procedure) |
| Adrenalectomy of remaining gland |
Excision of right adrenal gland (procedure) |
| Adrenalectomy of remaining gland |
Excision of left adrenal gland (procedure) |
| Adrenaline 1:1000 1mg/1mL injection (disorder) |
Product containing precisely epinephrine (as epinephrine bitartrate) 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Adrenogenital disorders (& [feminisation] or [virilisation] or [Achard-Thiers syndrome]) (disorder) |
Virilisation-adrenogenital syndrome |
| Adrenogenital disorders (& [feminisation] or [virilisation] or [Achard-Thiers syndrome]) (disorder) |
Achard-Thiers syndrome |
| Adrenogenital disorders (& [feminisation] or [virilisation] or [Achard-Thiers syndrome]) (disorder) |
Feminisation-adrenogenital syndrome |
| Adrenogenital disorders (& [feminisation] or [virilisation] or [Achard-Thiers syndrome]) (disorder) |
Adrenogenital disorder |
| Adult ABNORMAL - deleted |
Chronic disease monitoring status |
| Adult ABNORMAL - deleted |
Chronic disease monitoring status |
| types N adulte |
Functional assessment |
| Adult ascariasis |
Ascariasis caused by adult Ascaris |
| Adult health examination (& [triennial] or [well man] or [well woman]) |
Well woman health examination |
| Adult health examination (& [triennial] or [well man] or [well woman]) |
bilan de santé d'un homme |
| Adult health examination (& [triennial] or [well man] or [well woman]) |
Triennial health examination |
| Adult health examination (& [triennial] or [well man] or [well woman]) |
bilan de santé d'un homme |
| Adult health examination (& [triennial] or [well man] or [well woman]) |
Triennial health examination |
| Adult health examination (& [triennial] or [well man] or [well woman]) |
Well woman health examination |
| Adult health examination (& [triennial] or [well man] or [well woman]) |
examen de santé d'un adulte |
| Adult health examination (& [triennial] or [well man] or [well woman]) |
examen de santé d'un adulte |
| Adult junctional epidermolysis bullosa |
Late-onset junctional epidermolysis bullosa (disorder) |
| Adult junctional epidermolysis bullosa |
Junctional epidermolysis bullosa mitis |
| Adult lymphedema |
Primary lymphedema tardum (disorder) |
| Adult victim of abuse (finding) |
Adult victim of abuse (finding) |
FHIR